MedPath

Tasso Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

A Multi-site Clinical Evaluation of Capillary Blood Samples Collected Using the Tasso+SST Device for Downstream Analyte Testing

Recruiting
Conditions
Serum Analytes
First Posted Date
2024-04-30
Last Posted Date
2024-05-02
Lead Sponsor
Tasso Inc.
Target Recruit Count
220
Registration Number
NCT06392269
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Tasso Research Clinic, Seattle, Washington, United States

A Comparator Study of a Tasso Device Blood Sample to Traditional Venous Blood Sample for CBC

Not yet recruiting
Conditions
Neutropenia
Leukocytosis
Leukopenia
First Posted Date
2024-04-11
Last Posted Date
2024-05-21
Lead Sponsor
Tasso Inc.
Target Recruit Count
40
Registration Number
NCT06360952
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

ALT Routinely Recorded Remotely: A Comparator Study of Liver Function Tests Using the Tasso+ to Venipuncture.

Conditions
Elevated Alanine Transaminase (ALT)
First Posted Date
2022-02-28
Last Posted Date
2022-02-28
Lead Sponsor
Tasso Inc.
Target Recruit Count
80
Registration Number
NCT05259618
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

๐Ÿ‡บ๐Ÿ‡ธ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

EvergreenHealth Research, Kirkland, Washington, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.